ClinConnect ClinConnect Logo
Search / Trial NCT06940843

A Pilot Randomized Controlled Trial of the Hopeful and Healthy Living Program

Launched by BOSTON UNIVERSITY CHARLES RIVER CAMPUS · Apr 22, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Psychosocial Interventions Cognitive Interventions Social Skills Interventions Healthy Lifestyle Interventions Older Adults With Smi

ClinConnect Summary

This clinical trial is studying a new program called the Hopeful and Healthy Living (HHL) intervention, designed to help adults over 50 who have serious mental illnesses. The main aim is to see if this program can help participants feel more socially connected and encourage them to adopt healthier lifestyles, such as better sleep, physical activity, and improved eating habits. Participants will either join the HHL program, which includes social skills training and strategies to manage their thoughts and feelings, or continue with their usual treatment. Researchers will measure changes in how supported and connected they feel, their overall mental health, cognitive abilities (like memory and thinking skills), and healthy behaviors over the course of a year.

To be eligible for this trial, participants must be at least 50 years old, have a diagnosis of a serious mental illness, and be a member of a specific community program in Boston. Those with dementia or certain other neurological disorders cannot participate. If you join the study, you will complete assessments at the start and then again at 4, 8, and 12 months to track your progress. This is an exciting opportunity to contribute to research that could help improve the lives of older adults with serious mental health challenges.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 50 years or older, diagnosis of a serious mental illness, and a member of Center Club or Transitions of Boston
  • Exclusion Criteria:
  • Diagnosis of dementia or other progressive neurological disorder

About Boston University Charles River Campus

Boston University Charles River Campus is a prominent academic institution dedicated to advancing health and science through innovative research and education. As a sponsor of clinical trials, the campus leverages its extensive resources and interdisciplinary expertise to facilitate groundbreaking studies that aim to improve patient outcomes and contribute to the understanding of various medical conditions. With a commitment to ethical research practices and collaboration with healthcare professionals, Boston University Charles River Campus plays a vital role in translating scientific discoveries into clinical applications that benefit communities locally and globally.

Locations

Boston, Massachusetts, United States

Boston, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Susan McGurk, PhD

Principal Investigator

Boston University

Kim Mueser, PhD

Principal Investigator

Boston University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported